Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Choline kinase alpha (CHK) Antibody (C-term) [APR15425G] | Login | Choline kinase alpha (CHK) Antibody (C-term) [APR15425G] | ||||||||||||||||
|
||||||||||||||||||
| ENT1 (Slc29a1) Antibody (S254) [APR15841G] | Login | ENT1 (Slc29a1) Antibody (S254) [APR15841G] | ||||||||||||||||
|
||||||||||||||||||
| FZD3 Antibody (C-term) [APR16062G] | Login | FZD3 Antibody (C-term) [APR16062G] | ||||||||||||||||
|
||||||||||||||||||
| CD3Z Antibody (C-term) [APR15349G] | Login | CD3Z Antibody (C-term) [APR15349G] | ||||||||||||||||
|
||||||||||||||||||
| CYK18 Antibody (C-term) [APR15651G] | Login | CYK18 Antibody (C-term) [APR15651G] | ||||||||||||||||
|
||||||||||||||||||
| Diacylglycerol kinase iota (DGKI) Antibody (C-term) [APR15734G] | Login | Diacylglycerol kinase iota (DGKI) Antibody (C-term) [APR15734G] | ||||||||||||||||
|
||||||||||||||||||
| CYK18 Antibody (C-term) [APR15652G] | Login | CYK18 Antibody (C-term) [APR15652G] | ||||||||||||||||
|
||||||||||||||||||
| CTLA4 Antibody (N-term) [APR15622G] | Login | CTLA4 Antibody (N-term) [APR15622G] | ||||||||||||||||
|
||||||||||||||||||
| ENT1 (Slc29a1) Antibody (S254) [APR15841G] | Login | ENT1 (Slc29a1) Antibody (S254) [APR15841G] | ||||||||||||||||
|
||||||||||||||||||
| FZD3 Antibody (C-term) [APR16062G] | Login | FZD3 Antibody (C-term) [APR16062G] | ||||||||||||||||
|
||||||||||||||||||
| CD3Z Antibody (N-term) [APR15350G] | Login | CD3Z Antibody (N-term) [APR15350G] | ||||||||||||||||
|
||||||||||||||||||
| CD3Z Antibody (C-term) [APR15349G] | Login | CD3Z Antibody (C-term) [APR15349G] | ||||||||||||||||
|
||||||||||||||||||
| Chemokine Receptor D6 (CCBP2) Antibody (N-term) [APR15439G] | Login | Chemokine Receptor D6 (CCBP2) Antibody (N-term) [APR15439G] | ||||||||||||||||
|
||||||||||||||||||
| Chemokine Receptor D6 (CCBP2) Antibody (C-term) [APR15438G] | Login | Chemokine Receptor D6 (CCBP2) Antibody (C-term) [APR15438G] | ||||||||||||||||
|
||||||||||||||||||
| Annexin A1 Antibody (Center) [APR14932G] | Login | Annexin A1 Antibody (Center) [APR14932G] | ||||||||||||||||
|
||||||||||||||||||
| Choline kinase alpha (CHK) Antibody (C-term) [APR15425G] | Login | Choline kinase alpha (CHK) Antibody (C-term) [APR15425G] | ||||||||||||||||
|
||||||||||||||||||
| CTLA4 Antibody (N-term) [APR15622G] | Login | CTLA4 Antibody (N-term) [APR15622G] | ||||||||||||||||
|
||||||||||||||||||
| ENT1 (Slc29a1) Antibody (S254) [APR15841G] | Login | ENT1 (Slc29a1) Antibody (S254) [APR15841G] | ||||||||||||||||
|
||||||||||||||||||
| CD3Z Antibody (N-term) [APR15350G] | Login | CD3Z Antibody (N-term) [APR15350G] | ||||||||||||||||
|
||||||||||||||||||
| Chemokine Receptor D6 (CCBP2) Antibody (N-term) [APR15439G] | Login | Chemokine Receptor D6 (CCBP2) Antibody (N-term) [APR15439G] | ||||||||||||||||
|
||||||||||||||||||
| Chemokine Receptor D6 (CCBP2) Antibody (C-term) [APR15438G] | Login | Chemokine Receptor D6 (CCBP2) Antibody (C-term) [APR15438G] | ||||||||||||||||
|
||||||||||||||||||
| PIST Antibody (C-term) [APR14375G] | Login | PIST Antibody (C-term) [APR14375G] | ||||||||||||||||
|
||||||||||||||||||
| PPP6C Antibody (C-term) [APR14379G] | Login | PPP6C Antibody (C-term) [APR14379G] | ||||||||||||||||
|
||||||||||||||||||
| MARK2 (EMK) Antibody (C-term) [APR14355G] | Login | MARK2 (EMK) Antibody (C-term) [APR14355G] | ||||||||||||||||
|
||||||||||||||||||
| ENT1 Antibody (Center) [APR14332G] | Login | ENT1 Antibody (Center) [APR14332G] | ||||||||||||||||
|
||||||||||||||||||


